See also this year's filing and all EDGAR filings for this company.
PDF Report 0001388320_2026_Actinium_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001388320, Actinium Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 49,381,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 295,000 |
| 3 | remainder_Assets | 2,099,000 |
| 4 | LiabilitiesCurrent | 7,969,000 |
| 5 | LiabilitiesNoncurrent | 35,972,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,551,822 |
| 9 | ResearchAndDevelopmentExpense | 20,363,885 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 91,953 |
| 12 | remainder_NetIncome | 2,389,483 |
| 13 | remainder_ComprehensiveNetIncome | -20,058 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 51,775,000 |
| 1 | Liabilities | 43,941,000 |
| 2 | Expenses | 35,915,707 |
| 3 | Revenues | 91,953 |
| 4 | StockholdersEquity | 7,834,000 |
| 5 | NetIncome | -33,434,271 |
| 6 | ComprehensiveNetIncome | -33,444,300 |
| 7 | BaseVar | 67,066,600 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.342 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
